Infectious diseases are responsible for more deaths worldwide than any other single cause. With new and emerging pandemics, antibiotics that are no longer effective and environmental changes, infectious diseases pose a continual and rising threat to humankind. Some infectious diseases can now be combated through vaccination and effective treatment; however, there are still many more that cannot.
No single company or institution can tackle the enormity of infectious diseases alone and we, at Janssen, believe that it will take collaboration. There is more to be discovered by working together, and through this, we are confident that innovation can be achieved, diseases tackled and lives saved.
We have a strong heritage in collaborative partnerships and a proven track record in the rapid development of and access to innovative treatments. We want to partner with the best and brightest: those who are committed to providing real solutions. Whether from academia, government, or other companies and institutions, we seek partnerships and ideas that will have a lasting impact on the lives of those we care about. Innovation is central to our strategy, and we do not confine it to the space within our walls. Wherever the next advance lies, that is where we will be.
From discovery to development to reimbursement, a partnership strategy with the appropriate organizations or institutions may prove to be the most viable option for success. We are committed to exploring diverse, mutually beneficial, partnership models that will accelerate the discovery and development of new therapies and vaccines. We have a “partner of choice” reputation with academic institutions, biotechs, public-private partnerships and open campus initiatives due to our truly global capabilities, our flexibility and risk-sharing mentality.
If you have a licensing candidate or program idea that you feel may be of interest to Janssen Research & Development, LLC, we invite you to submit this idea on the contact form located here.